Annual Current Assets
$679.50 M
-$530.90 M-43.86%
31 December 2023
Summary:
Emergent BioSolutions annual total current assets is currently $679.50 million, with the most recent change of -$530.90 million (-43.86%) on 31 December 2023. During the last 3 years, it has fallen by -$516.40 million (-43.18%). EBS annual current assets is now -46.49% below its all-time high of $1.27 billion, reached on 31 December 2021.EBS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$661.40 M
+$6.90 M+1.05%
30 September 2024
Summary:
Emergent BioSolutions quarterly total current assets is currently $661.40 million, with the most recent change of +$6.90 million (+1.05%) on 30 September 2024. Over the past year, it has dropped by -$59.40 million (-8.24%). EBS quarterly current assets is now -47.92% below its all-time high of $1.27 billion, reached on 31 December 2021.EBS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.9% | -8.2% |
| 3 y3 years | -43.2% | -40.5% |
| 5 y5 years | +9.5% | -5.5% |
EBS Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -46.5% | at low | -47.9% | +1.1% |
| 5 y | 5 years | -46.5% | +9.5% | -47.9% | +5.5% |
| alltime | all time | -46.5% | >+9999.0% | -47.9% | +1486.3% |
Emergent BioSolutions Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $661.40 M(+1.1%) |
| June 2024 | - | $654.50 M(-4.1%) |
| Mar 2024 | - | $682.40 M(+0.4%) |
| Dec 2023 | $1.14 B(-41.5%) | $679.50 M(-5.7%) |
| Sept 2023 | - | $720.80 M(-7.3%) |
| June 2023 | - | $777.70 M(-36.3%) |
| Mar 2023 | - | $1.22 B(+0.9%) |
| Dec 2022 | $1.96 B(+15.9%) | $1.21 B(+8.2%) |
| Sept 2022 | - | $1.12 B(+3.2%) |
| June 2022 | - | $1.08 B(-1.5%) |
| Mar 2022 | - | $1.10 B(-13.4%) |
| Dec 2021 | $1.69 B(+0.0%) | $1.27 B(+14.3%) |
| Sept 2021 | - | $1.11 B(-4.4%) |
| June 2021 | - | $1.16 B(-1.6%) |
| Mar 2021 | - | $1.18 B(-1.2%) |
| Dec 2020 | $1.69 B(+2.8%) | $1.20 B(+24.7%) |
| Sept 2020 | - | $958.80 M(+20.5%) |
| June 2020 | - | $795.90 M(+27.0%) |
| Mar 2020 | - | $626.60 M(-8.7%) |
| Dec 2019 | $1.64 B(+2.0%) | $686.20 M(-2.0%) |
| Sept 2019 | - | $700.00 M(+1.1%) |
| June 2019 | - | $692.70 M(+31.1%) |
| Mar 2019 | - | $528.50 M(-14.9%) |
| Dec 2018 | $1.61 B(+175.1%) | $620.80 M(+10.2%) |
| Sept 2018 | - | $563.15 M(+4.0%) |
| June 2018 | - | $541.31 M(+13.6%) |
| Mar 2018 | - | $476.65 M(-1.8%) |
| Dec 2017 | $584.80 M(+27.2%) | $485.40 M(-12.7%) |
| Sept 2017 | - | $556.03 M(+9.1%) |
| June 2017 | - | $509.74 M(+4.2%) |
| Mar 2017 | - | $489.17 M(-4.1%) |
| Dec 2016 | $459.89 M(-8.0%) | $510.22 M(+6.3%) |
| Sept 2016 | - | $480.00 M(-9.1%) |
| June 2016 | - | $528.05 M(-0.0%) |
| Mar 2016 | - | $528.16 M(-1.7%) |
| Dec 2015 | $500.07 M | $537.41 M(+13.5%) |
| Sept 2015 | - | $473.49 M(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $435.49 M(+7.3%) |
| Mar 2015 | - | $405.81 M(-6.1%) |
| Dec 2014 | $506.52 M(+43.3%) | $432.18 M(+12.7%) |
| Sept 2014 | - | $383.63 M(+11.1%) |
| June 2014 | - | $345.45 M(+5.6%) |
| Mar 2014 | - | $327.20 M(+19.8%) |
| Dec 2013 | $353.51 M(+17.5%) | $273.12 M(+16.7%) |
| Sept 2013 | - | $234.01 M(-5.7%) |
| June 2013 | - | $248.16 M(+4.7%) |
| Mar 2013 | - | $237.08 M(-10.0%) |
| Dec 2012 | $300.88 M(+2.9%) | $263.35 M(+4.1%) |
| Sept 2012 | - | $252.94 M(+4.0%) |
| June 2012 | - | $243.22 M(+1.5%) |
| Mar 2012 | - | $239.54 M(-5.8%) |
| Dec 2011 | $292.45 M(+13.9%) | $254.42 M(+7.5%) |
| Sept 2011 | - | $236.76 M(+5.8%) |
| June 2011 | - | $223.84 M(+3.5%) |
| Mar 2011 | - | $216.20 M(-11.2%) |
| Dec 2010 | $256.83 M(+70.2%) | $243.49 M(+15.5%) |
| Sept 2010 | - | $210.84 M(+8.4%) |
| June 2010 | - | $194.45 M(+1.5%) |
| Mar 2010 | - | $191.54 M(-1.2%) |
| Dec 2009 | $150.88 M(+9.4%) | $193.81 M(-0.8%) |
| Sept 2009 | - | $195.42 M(-4.1%) |
| June 2009 | - | $203.72 M(+24.3%) |
| Mar 2009 | - | $163.92 M(+7.4%) |
| Dec 2008 | $137.90 M(+6.7%) | $152.68 M(+0.5%) |
| Sept 2008 | - | $151.97 M(+8.5%) |
| June 2008 | - | $140.03 M(+0.3%) |
| Mar 2008 | - | $139.63 M(-3.2%) |
| Dec 2007 | $129.20 M(+42.1%) | $144.31 M(+34.4%) |
| Sept 2007 | - | $107.36 M(+7.8%) |
| June 2007 | - | $99.61 M(-3.9%) |
| Mar 2007 | - | $103.69 M(-29.6%) |
| Dec 2006 | $90.92 M(+120.6%) | $147.34 M(+157.6%) |
| Sept 2006 | - | $57.19 M(-3.3%) |
| Dec 2005 | $41.22 M(+50.6%) | $59.12 M(+41.8%) |
| Dec 2004 | $27.36 M | $41.70 M |
FAQ
- What is Emergent BioSolutions annual total current assets?
- What is the all time high annual current assets for Emergent BioSolutions?
- What is Emergent BioSolutions annual current assets year-on-year change?
- What is Emergent BioSolutions quarterly total current assets?
- What is the all time high quarterly current assets for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly current assets year-on-year change?
What is Emergent BioSolutions annual total current assets?
The current annual current assets of EBS is $679.50 M
What is the all time high annual current assets for Emergent BioSolutions?
Emergent BioSolutions all-time high annual total current assets is $1.27 B
What is Emergent BioSolutions annual current assets year-on-year change?
Over the past year, EBS annual total current assets has changed by -$530.90 M (-43.86%)
What is Emergent BioSolutions quarterly total current assets?
The current quarterly current assets of EBS is $661.40 M
What is the all time high quarterly current assets for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly total current assets is $1.27 B
What is Emergent BioSolutions quarterly current assets year-on-year change?
Over the past year, EBS quarterly total current assets has changed by -$59.40 M (-8.24%)